Back to top
more

Neovasc Inc. (NVCN)

(Delayed Data from NSDQ)

$0.50 USD

0.50
470,511

+0.01 (2.96%)

Updated May 3, 2019 03:59 PM ET

After-Market: $0.49 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

1 item in cart

View Cart/Checkout

[NVCN]

Reports for Purchase

Showing records 1 - 20 ( 33 total )

Industry: Medical - Instruments

Record: 1

03/06/2023

Industry Report

Pages: 4

Event Driven A.M. Note

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 2

01/18/2023

Company Report

Pages: 3

VERY HONORABLE

Provider: Bloom Burton & Company

Analyst: MARTIN D

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 3

01/18/2023

Company Report

Pages: 4

Shockwave Medical Enters Into Definitive Agreement to Acquire Neovasc For $100M; Downgrading to Neutral with a $27.25 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 4

11/15/2022

Company Report

Pages: 4

3Q22: Another Record-Breaking Quarter; Reiterate Buy and $20 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 5

08/22/2022

Company Report

Pages: 5

Strong 1H22 Accomplishments Underappreciated; Reiterate Buy Rating With PT Adjusted to $20

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 6

08/12/2022

Company Report

Pages: 3

2Q-2022 Results - Green Shoots.

Provider: Bloom Burton & Company

Analyst: MARTIN D

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 7

03/11/2022

Company Report

Pages: 5

Expecting Imetelstat Clinical Programs to Make Steady Progress in 2022; Reiterate Buy Rating and $7 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 8

12/01/2021

Company Report

Pages: 4

PECT Reimbursement Evidence of Strong Support for Reducer; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 9

11/12/2021

Company Report

Pages: 4

A Meaningful Beat in 3Q21 Reducer Revenues; Reiterate Buy Rating and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 10

11/09/2021

Company Report

Pages: 4

Expecting Stable Reducer Growth Despite COVID-19 Challenges; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 5.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 11

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for NVCN

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 12

08/11/2021

Company Report

Pages: 5

Strong 2Q Despite COVID-19 Challenges; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 13

06/18/2021

Company Report

Pages: 5

Strategic Initiatives Conserve Cash and Potentially Enhance Reducer Growth; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 14

05/07/2021

Company Report

Pages: 5

Strength Demonstrated Against COVID-19 Headwinds; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 15

04/01/2021

Company Report

Pages: 5

Well-Positioned to Accelerate Growth Activities in 2021; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 16

02/26/2021

Company Report

Pages: 4

We?re Positive on Strong Reducer Momentum in 2021; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 17

12/15/2020

Daily Note

Pages: 3

Reducer Makes Important Steps in Target France Market; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 18

11/06/2020

Company Report

Pages: 5

3Q20 Results Indicative of What?s Possible in a Non-COVID World; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 19

08/19/2020

Company Report

Pages: 5

2Q Results and Stronger Balance Sheet Mark Growing 2H20 Momentum; Reiterate Buy and $5 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Instruments

Record: 20

07/02/2020

Company Report

Pages: 3

Positive Interim Results From REDUCER-I Reinforce Sustained Therapeutic Efficacy

Provider: H.C. Wainwright & Co., Inc.

Analyst: BERNARDINO V

Price: 10.00

Research Provided by a Third Party
// eof